 <h1>Haemophilus b conjugate (prp-t) vaccine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to haemophilus b conjugate (prp-t) vaccine: intramuscular powder for solution, intramuscular powder for suspension, intramuscular solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, haemophilus b conjugate (prp-t) vaccine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking haemophilus b conjugate (prp-t) vaccine:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>loss of appetite</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Earache</li>
<li>redness or swelling in the ear</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Chest pain</li>
<li>chills</li>
<li>cough</li>
<li>fever over 102 degrees F (39 degrees C)</li>
<li>lack or loss of strength</li>
<li>seizures</li>
<li>sneezing</li>
<li>sore throat</li>
<li>tightness in the chest</li>
<li>troubled breathing</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>bluish lips or skin</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>hives or welts, skin rash</li>
<li>itching (especially of the feet or hands)</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>rapid weight gain</li>
<li>reddening of the skin (especially around the ears)</li>
<li>swelling of the eyes, face, or inside of the nose</li>
<li>swollen, painful, or tender lymph glands in the neck, armpit, or groin</li>
<li>tingling of the hands or feet</li>
<li>unusual tiredness or weakness (sudden and severe)</li>
<li>unusual weight gain or loss</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of haemophilus b conjugate (prp-t) vaccine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Fever less than 102 degrees F (39 degrees C) </li>
<li>irritability</li>
<li>redness, pain, swelling, tenderness, or warm feeling at the injection site</li>
<li>reduced physical activity</li>
<li>restlessness</li>
<li>sleepiness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Prolonged crying lasting more than 4 hours</li>
<li>unusual high-pitched crying</li>
</ul><p>
<!-- end intramuscular powder for solution, intramuscular powder for suspension, intramuscular solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to haemophilus b conjugate (prp-t) vaccine: intramuscular powder for injection</i></p><h3>General</h3><p>The most common adverse events were pain and redness at the injection site, irritability, drowsiness, fever, loss of appetite, fussiness, and restlessness.  Most symptoms occur in the first 48 hours, are mild, and resolve spontaneously.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Pain (49.4%), redness (29.4%), tenderness (20%), swelling (18.7%)</p>
<p><b>Common</b> (1% to 10%): Induration</p>
<p><b>Very rare</b> (less than 0.01%): Extensive swelling of vaccinated limb, injection site induration<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Drowsiness (59.9%), decreased activity/lethargy (51.1%), sleepiness (19.9%)</p>
<p><b>Rare</b> (less than 0.1%): Seizure with apnea, convulsion</p>
<p><b>Very rare</b> (less than 0.01%): Convulsions (with or without fever), hypotonic-hyporesponsive episode (e.g.  sudden onset of hypotonia, hyporesponsiveness, and pallor or cyanosis), somnolence, syncope, vasovagal responses to injection<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Irritability (70.4%), fussiness (25.9%), restlessness (21.8%)</p>
<p><b>Common</b> (1% to 10%): Nervousness</p>
<p><b>Uncommon</b> (0.1% to 1%): Emotional lability, insomnia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Inconsolable crying (58.5%), fever (34.8%)</p>
<p><b>Common</b> (1% to 10%): Otitis media</p>
<p><b>Uncommon</b> (0.1% to 1%): Asthenia, fatigue, injury</p>
<p><b>Postmarketing reports</b>: Peripheral edema<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Loss of appetite (28.7%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (14.6%), vomiting</p>
<p><b>Common</b> (1% to 10%): Gastroenteritis</p>
<p><b>Uncommon</b> (0.1% to 1%): Abdominal pain<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash erythematous</p>
<p><b>Uncommon</b> (0.1% to 1%): Sweating increased, purpura</p>
<p><b>Very rare</b> (less than 0.01%): Angioedema, rash, urticaria</p>
<p><b>Postmarketing reports</b>: Pruritus<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis, coughing, respiratory disorder, upper respiratory tract infection, bronchitis</p>
<p><b>Rare</b> (less than 0.1%): Bilateral pneumonia</p>
<p><b>Very rare</b> (less than 0.01%): Apnea in very premature infants<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Allergic reactions (including anaphylactic and anaphylactoid reactions)</p>
<p><b>Postmarketing reports</b>: Other allergic/hypersensitivity reactions (including urticaria, angioedema)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Spastic paralysis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Viral infection<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. ActHIB (haemophilus b conjugate (PRP-T) vaccine)." sanofi pasteur, Swiftwater, PA. </p><p id="ref_2">2. "Product Information. Hiberix (haemophilus b conjugate (PRP-T) vaccine)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about haemophilus b conjugate (prp-t) vaccine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: bacterial vaccines</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Haemophilus b conjugate vaccine Intramuscular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>ActHIB, Hiberix</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Haemophilus influenzae Prophylaxis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to haemophilus b conjugate (prp-t) vaccine: intramuscular powder for injection</i></p><h3>General</h3><p>The most common adverse events were pain and redness at the injection site, irritability, drowsiness, fever, loss of appetite, fussiness, and restlessness.  Most symptoms occur in the first 48 hours, are mild, and resolve spontaneously.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Pain (49.4%), redness (29.4%), tenderness (20%), swelling (18.7%)</p><p><b>Common</b> (1% to 10%): Induration</p><p><b>Very rare</b> (less than 0.01%): Extensive swelling of vaccinated limb, injection site induration<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Drowsiness (59.9%), decreased activity/lethargy (51.1%), sleepiness (19.9%)</p><p><b>Rare</b> (less than 0.1%): Seizure with apnea, convulsion</p><p><b>Very rare</b> (less than 0.01%): Convulsions (with or without fever), hypotonic-hyporesponsive episode (e.g.  sudden onset of hypotonia, hyporesponsiveness, and pallor or cyanosis), somnolence, syncope, vasovagal responses to injection<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Irritability (70.4%), fussiness (25.9%), restlessness (21.8%)</p><p><b>Common</b> (1% to 10%): Nervousness</p><p><b>Uncommon</b> (0.1% to 1%): Emotional lability, insomnia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Inconsolable crying (58.5%), fever (34.8%)</p><p><b>Common</b> (1% to 10%): Otitis media</p><p><b>Uncommon</b> (0.1% to 1%): Asthenia, fatigue, injury</p><p><b>Postmarketing reports</b>: Peripheral edema<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Loss of appetite (28.7%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (14.6%), vomiting</p><p><b>Common</b> (1% to 10%): Gastroenteritis</p><p><b>Uncommon</b> (0.1% to 1%): Abdominal pain<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash erythematous</p><p><b>Uncommon</b> (0.1% to 1%): Sweating increased, purpura</p><p><b>Very rare</b> (less than 0.01%): Angioedema, rash, urticaria</p><p><b>Postmarketing reports</b>: Pruritus<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis, coughing, respiratory disorder, upper respiratory tract infection, bronchitis</p><p><b>Rare</b> (less than 0.1%): Bilateral pneumonia</p><p><b>Very rare</b> (less than 0.01%): Apnea in very premature infants<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Allergic reactions (including anaphylactic and anaphylactoid reactions)</p><p><b>Postmarketing reports</b>: Other allergic/hypersensitivity reactions (including urticaria, angioedema)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Spastic paralysis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Viral infection<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. ActHIB (haemophilus b conjugate (PRP-T) vaccine)." sanofi pasteur, Swiftwater, PA. </p><p id="ref_2">2. "Product Information. Hiberix (haemophilus b conjugate (PRP-T) vaccine)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about haemophilus b conjugate (prp-t) vaccine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: bacterial vaccines</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Haemophilus b conjugate vaccine Intramuscular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Haemophilus influenzae Prophylaxis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>